NEW YORK--(BUSINESS WIRE)--Regulatory News:
Philip Morris International Inc. (NYSE: PM) will host a live audio webcast of its 2021 Annual Meeting of Shareholders on Wednesday, May 5, 2021 at 9:00 a.m. ET. The meeting will be held in a virtual format only and can be accessed at www.virtualshareholdermeeting.com/PMI2021.
During the meeting, André Calantzopoulos, Executive Chairman of the Board, and Jacek Olczak, Chief Executive Officer*, will address shareholders and answer questions. Only shareholders of record with a valid 16-digit control number will be allowed to ask a question or make a comment.
The audio webcast may also be accessed on iOS or Android devices by downloading PMI’s free Investor Relations Mobile Application at www.pmi.com/irapp.
An archived copy of the webcast will be available for approximately one year from the date of the meeting at www.virtualshareholdermeeting.com/PMI2021.
Presentation slides and script will also be available at www.virtualshareholdermeeting.com/PMI2021.
*As announced by the Board of Directors on December 10, 2020, Mr. Olczak will succeed Mr. Calantzopoulos as Chief Executive Officer immediately following the meeting.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, PMI ships versions of its IQOS Platform 1 device and consumables to Altria Group, Inc. for sale under license in the U.S., where these products have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn and nicotine-containing vapor products. As of March 31, 2021, PMI's smoke-free products are available for sale in 66 markets in key cities or nationwide, and PMI estimates that approximately 14.0 million adults around the world have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.